Plain-English translation of NCT06088303 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two proven PTSD treatments—cognitive processing therapy and prolonged exposure—work better when paired with a new communication tool called AWARE. AWARE includes a brief writing exercise where you share your treatment experiences, and your therapist responds in a structured way to help you both communicate more effectively. The goal is to see if this added communication support helps people with PTSD recover more fully.
While the standard PTSD treatments are effective, many people still struggle with their symptoms. Researchers believe that improving how patients and therapists talk to each other during treatment could lead to better outcomes.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will first choose whether you want cognitive processing therapy or prolonged exposure—both are proven treatments for PTSD. You will then be randomly assigned to receive either the standard version of your chosen treatment or the same treatment with the added AWARE writing exercise and improved communication. You will attend weekly therapy sessions over 8–15 weeks, completing assessments along the way to track your progress.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Boston University
Collaborators
National Institute of Mental Health (NIMH)
Enrollment target
~54 participants
Started
January 2025
Primary completion
October 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Elizabeth Alpert, PhD
National Center for PTSD at VA Boston Healthcare System, BU School of Medicine, Psychiatry
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.